Want to see JP:6099 full AI Analyst Report?
Top Page
Elan Corp.
(6099)
Select Model
Select Model
Rating:73Outperform
Price Target:
¥842.00
▲(9.07% Upside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by strong financial performance—especially the low-leverage balance sheet and steady growth—partly tempered by margin compression and uneven cash conversion. Valuation is supportive with a reasonable P/E and moderate dividend yield. Technical signals are mixed, with short-term weakness against the 20-day average despite longer-term trend support.
Positive Factors
Conservative balance sheet
Extremely low leverage and expanding equity give durable financial flexibility. With debt-to-equity ~0.05 and equity growth alongside assets, the company can fund investments, weather downturns, pursue acquisitions or return capital without stressing liquidity, supporting long-term stability.
Negative Factors
Margin compression
Eroding operating and net margins point to structural cost pressure or adverse mix that reduces profitability per unit of revenue. Persisting margin compression weakens cash flow margins, limits reinvestment, and reduces the buffer to absorb economic shocks absent efficiency or pricing improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Extremely low leverage and expanding equity give durable financial flexibility. With debt-to-equity ~0.05 and equity growth alongside assets, the company can fund investments, weather downturns, pursue acquisitions or return capital without stressing liquidity, supporting long-term stability.
Read all positive factors
Elan Corp. (6099) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥45.83B
Dividend Yield1.93%
Average Volume (3M)89.05K
Price to Earnings (P/E)14.8
Beta (1Y)0.43
Revenue Growth12.86%
EPS Growth30.95%
CountryJP
Employees974
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)48.24
Shares Outstanding60,600,000
10 Day Avg. Volume77,090
30 Day Avg. Volume89,046
Financial Highlights & Ratios
PEG Ratio0.90
Price to Book (P/B)3.03
Price to Sales (P/S)0.79
P/FCF Ratio13.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)52.6
Revenue Forecast (FY)¥60.60B
Elan Corp. Business Overview & Revenue Model
Company Description
Elan Corporation operates within the healthcare sector, specializing in nursing and medical services. The company offers a rental and laundry service for crucial daily items such as clothing, towels, and diapers, primarily catering to patients in ...
How the Company Makes Money
null...
Elan Corp. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.78B | 55.45B | 47.51B | 41.43B | 36.26B | 31.64B |
| Gross Profit | 12.28B | 11.87B | 10.72B | 9.75B | 9.03B | 7.88B |
| EBITDA | 5.63B | 5.59B | 4.49B | 3.85B | 3.53B | 2.92B |
| Net Income | 2.92B | 2.77B | 2.35B | 2.52B | 2.08B | 1.91B |
Balance Sheet | ||||||
| Total Assets | 25.76B | 26.23B | 21.61B | 18.99B | 16.07B | 13.95B |
| Cash, Cash Equivalents and Short-Term Investments | 5.63B | 6.85B | 6.85B | 5.49B | 6.04B | 5.63B |
| Total Debt | 685.20M | 765.20M | 86.57M | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 10.83B | 11.55B | 9.10B | 8.18B | 7.08B | 6.46B |
| Stockholders Equity | 14.52B | 14.44B | 12.50B | 10.81B | 8.99B | 7.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.18B | 3.62B | 1.59B | 1.23B | 2.03B |
| Operating Cash Flow | 0.00 | 4.29B | 4.50B | 1.78B | 1.58B | 2.11B |
| Investing Cash Flow | 0.00 | -3.39B | -2.23B | -1.66B | -624.51M | -357.68M |
| Financing Cash Flow | 0.00 | -906.86M | -849.53M | -667.09M | -552.96M | -614.15M |
Elan Corp. Technical Analysis
Positive
772.00
Price Trends
742.50
Positive
734.27
Positive
729.38
Positive
Market Momentum
2.42
Positive
48.78
Neutral
43.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6099, the sentiment is Positive. The current price of 772 is below the 20-day moving average (MA) of 772.30, above the 50-day MA of 742.50, and above the 200-day MA of 729.38, indicating a neutral trend. The MACD of 2.42 indicates Positive momentum. The RSI at 48.78 is Neutral, neither overbought nor oversold. The STOCH value of 43.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6099.
Elan Corp. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥47.41B | 11.26 | ― | 2.63% | 5.16% | 37.79% | |
73 Outperform | ¥45.83B | 14.82 | 21.08% | 1.94% | 12.86% | 30.95% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥2.57B | 30.31 | ― | 2.56% | -5.72% | -73.78% | |
49 Neutral | ¥5.44B | 51.99 | ― | 4.07% | 4.85% | -85.27% | |
46 Neutral | ¥4.78B | 15.70 | ― | 1.41% | 16.83% | -45.33% |
* Healthcare Sector Average
JP:6099
Elan Corp.
776.00
-14.69
-1.86%
JP:2373
Care Twentyone Corporation
405.00
-3.14
-0.77%
JP:2425
Care Service Co., Ltd.
674.00
-82.28
-10.88%
JP:6062
Charm Care Corporation
1,405.00
278.67
24.74%
JP:7061
Japan Hospice Holdings Inc.
566.00
-543.97
-49.01%
Elan Corp. Corporate Events
Elan Corp. Reports Q2 FY2026 Results and Unveils New Mid-Term Plan
Jul 31, 2026
Elan Corp. released its operating results for the second quarter of fiscal 2026 ended June 30, alongside an updated earnings forecast for the full fiscal year. The disclosure provides investors with visibility into recent performance and expectati...
Elan Corporation Delivers Robust First-Half 2026 Earnings and Confirms Full-Year Outlook
Jul 31, 2026
Elan Corporation reported strong first-half fiscal 2026 results under Japanese GAAP, with net sales rising 10.0% year on year to ¥29.5 billion and net profit attributable to owners of the parent climbing 27.2% to ¥1.74 billion. Earnings ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.